Publications by authors named "Amador Ruiz-Torrejon"
Background: Overactive bladder (OAB) is a syndrome characterized by presenting symptoms of urgency, with or without urge incontinence, and normally accompanied by day and night frequency.
Objective: The aim of this study was to evaluate the impact of lost work productivity [number of days of sick leave] in patients treated with fesoterodine versus tolterodine and solifenacin to treat OAB in Spain.
Methods: A retrospective, observational study was carried out using the records (digital databases) of actively working patients (2008-2013).
Article Synopsis
- This study investigated treatment persistence among patients with overactive bladder (OAB) receiving different antimuscarinic medications (fesoterodine, solifenacin, and tolterodine) in Spain.
- A total of 1,971 patient records were analyzed, revealing that 35.8% of patients on fesoterodine continued their treatment after 52 weeks, compared to lower rates for solifenacin (31.9%) and tolterodine (30.9%).
- The findings suggest that while overall persistence was low, patients on fesoterodine exhibited significantly higher persistence than those on the other two medications.
Background: Overactive bladder (OAB) is associated with high healthcare costs, which may be partially driven by drug treatment. There is little comparative data on antimuscarinic drugs with respect to resource use and costs. This study was conducted to address this gap and the growing need for naturalistic studies comparing health economics outcomes in adult patients with OAB syndrome initiating treatment with different antimuscarinic drugs in a primary care setting in Spain.
View Article and Find Full Text PDFObjective: To compare three methods of measuring multiple morbidity according to the use of health resources (cost of care) in primary healthcare (PHC).
Design: Retrospective study using computerized medical records.
Setting: Thirteen PHC teams in Catalonia (Spain).
Background: Controversy exists with regard to the impact that the different components of diagnosis delay may have on the degree of invasion and prognosis in patients with colorectal cancer. The follow-up strategies after treatment also vary considerably. The aims of this study are: a) to determine if the symptoms-to-diagnosis interval and the treatment delay modify the survival of patients with colorectal cancer, and b) to determine if different follow-up strategies are associated with a higher survival rate.
View Article and Find Full Text PDF